Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults
Charles Blizzard,1 Eugene B McLaurin,2 Arthur Driscoll,1 Fabiana Q Silva,1 Srilatha Vantipalli,1 Jamie Lynne Metzinger,1 Michael H Goldstein1 1Ocular Therapeutix, Inc., Bedford, MA, USA; 2Total Eye Care, Memphis, TN, USACorrespondence: Srilatha VantipalliOcular Therapeutix, Inc, 24 Crosby Drive, Bed...
Guardado en:
Autores principales: | Blizzard C, McLaurin EB, Driscoll A, Silva FQ, Vantipalli S, Metzinger JL, Goldstein MH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3d1044738c540a98e4e2930dfaa6914 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy
por: Suñer IJ, et al.
Publicado: (2021) -
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks CC, et al.
Publicado: (2020) -
Dexamethasone release from photopolymerised PEGDA700 for cochlea drug delivery
por: Thomas Eickner, et al.
Publicado: (2020) -
Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis
por: Foster B
Publicado: (2021) -
Treatment of Dry Eye With Intracanalicular Injection of Hydroxybutyl Chitosan: A Prospective Randomized Clinical Trial
por: Tong Lin, et al.
Publicado: (2021)